Simple keyword search and advanced search
close
or

NSW Health / HSSP_HC22_C868 INDUSTRY BRIEFING Pharmaceutical 4 - HSSP_HC22_C868 INDUSTRY BRIEFING

RFT ID HSSP_HC22_C868 INDUSTRY BRIEFING
RFT Type Open Tenders
Published 31-Jan-2023
Closes 3-Feb-2023 2:30pm
Category Drugs and Pharmaceutical Products
Agency HealthShare NSW


Contact Person
Lamya Yaqo
Phone: 0414038476
Lamya.Yaqo@health.nsw.gov.au

Tender Details

HSSP_HC22_C868 INDUSTRY BRIEFING for Pharmaceutical 4

HealthShare NSW will be conducting an Industry Briefing for the upcoming Tender for Pharmaceutical 4 – SOA#C868 – Lenalidomide Direct negotiation

This Pharmaceutical Tender is specifically for selection of Lenalidomide direct negotiations.

The Industry Briefing will be held with details below:

Date: 3rd February 2023

Time:   2:30pm (30min briefing + 10min Question time)

Location: MS Teams meeting (link provided upon RSVP)

Please RSVP via email to the undersigned below by:

1st February 2023 5.00p.m

Lamya Yago lamya.yaqo@health.nsw.gov.au

Location

NSW Regions: Far North Coast, Mid North Coast, New England, Central Coast, Hunter, Cumberland/Prospect, Nepean, Northern Sydney, Inner West, South East Sydney, South West Sydney, Central West, Orana/Far West, Riverina/Murray, Illawarra, Southern Highlands
States and Territories: ACT, NT, QLD, SA, TAS, VIC, WA

RFT Type

Open Tenders - An invitation to tender by public advertisement with no restriction placed on who may tender. Tenderers will normally be required to demonstrate in their tender that they have the necessary skills, resources, experience, financial capacity, and in some cases licences, accreditations, etc., to fulfil the tender requirements.

Multi Agency Access

Yes

Multi Agency Access Type

All Agencies